支气管动脉栓塞治疗咯血复发的研究进展  

Research Progress of Recurrence of Hemoptysis after Bronchial Artery Embolization

作　　者：袁华兰 刘冬冬 黄玲 彭莲华 YUAN Hualan;LIU Dongdong;HUANG Ling;PENG Lianhua(Obstetrics and Gynecology Department,Suichuan County Maternal and Child Health Hospital,Suichuan 343900,China;不详)

机构地区：[1]遂川县妇幼保健院妇产科,江西遂川343900 [2]井冈山大学附属医院介入血管外科(含心胸大血管外科),江西吉安343000 [3]吉安市介入治疗临床医学研究中心,江西吉安343000

出　　处：《中国医学创新》2024年第12期174-178,共5页Medical Innovation of China

基　　金：国家自然科学基金项目(8166020257);江西省教育厅科技一般项目(GJJ211019);吉安市科技计划项目(20211-115559)。

摘　　要：咯血作为一种潜在的危及生命的医疗紧急情况,病情凶险,死亡率极高。目前,支气管动脉栓塞术(bronchial arterial embolization,BAE)因其安全、有效、快速等优势,现被认为是临床治疗咯血的首选方案,特别是在紧急情况下。但尽管如此,咯血复发仍是BAE治疗后难以逃避的问题。本研究通过对咯血患者BAE治疗后咯血复发的现状、影响因素及预防措施进行综述,旨在为患者咯血复发率的降低和预后结局的改善提供参考依据,从而提高其生存质量。Hemoptysis,as a potential life threatening medical emergency,is dangerous and has a high mortality rate.At present,bronchial artery embolization(BAE)is considered to be the first choice for clinical treatment of hemoptysis,especially in emergencies,because of its advantages of safety,effectiveness and rapidity.However,the recurrence of hemoptysis is still an unavoidable problem after BAE treatment.This study reviews the current situation,influencing factors and intervention measures of hemoptysis recurrence in hemoptysis patients after BAE treatment,in order to provide reference for reducing the recurrence rate of hemoptysis and improving the prognosis of patients,and so as to improve their quality of life.

关 键 词：咯血 支气管动脉 栓塞 介入治疗 复发 

分 类 号：R441.7[医药卫生—诊断学]